As shown in Table 1, GC patients with lymph node involvement and distant metastasis exhibited higher MELK expression rates than patients without these characteristics (77.1% vs. 57.4%, p=0.010; 91.7% vs. 68.8%, p=0.024, respectively). The gene discussed is MELK; the disease is gastric cancer.